Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Plerixafor + tacrolimus) by MedRegen for Keloids: Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Keloids. According to GlobalData, Phase...
(Plerixafor + tacrolimus) by MedRegen for Spinal Cord Injury: Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Spinal Cord Injury. According to...
(Plerixafor + tacrolimus) by MedRegen for Diabetic Nephropathy: Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Diabetic Nephropathy. According to GlobalData,...
(Plerixafor + tacrolimus) by MedRegen for Inflammatory Bowel Disease: Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Inflammatory Bowel Disease. According to...
(Plerixafor + tacrolimus) by MedRegen for Traumatic Brain Injury: Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Traumatic Brain Injury. According to...
(Plerixafor + tacrolimus) by MedRegen for Acute Renal Failure (ARF) (Acute Kidney Injury): Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Acute Renal Failure (ARF) (Acute...
(Plerixafor + tacrolimus) by MedRegen for Transplant Rejection: Likelihood of Approval
(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Transplant Rejection. According to GlobalData,...